Table: begin end state 1 11 cytoplasmic 12 29 transmembrane 30 40 non-cytoplasmic 41 60 transmembrane 61 93 cytoplasmic 94 118 transmembrane 119 125 non-cytoplasmic 126 144 transmembrane 145 150 cytoplasmic 151 176 transmembrane 177 201 non-cytoplasmic 202 222 transmembrane 223 233 cytoplasmic 234 257 transmembrane 258 280 non-cytoplasmic 281 310 transmembrane 311 330 cytoplasmic 331 352 transmembrane 353 357 non-cytoplasmic 358 382 transmembrane 383 394 cytoplasmic 395 413 transmembrane 414 418 non-cytoplasmic 419 437 transmembrane 438 448 cytoplasmic 449 470 transmembrane 471 475 non-cytoplasmic
Input: >AO356_05260 MPQPIEKLRLGALVALVVGSMIGGGIFSLPQNMAARADVGAVLIGWAITAVGMLTLAFVF QTLANRKPELDSGVYAYAKAGFGDYMGFSSAWGYWISAWMGNVGYFVLLFSTLGYFFPVF GQGNTPVAIACASLLLWAVHFLVLRGIKEAAFINLVTTIAKVVPLVMFIVIAAVAFKAEV FTRDIWGEMNPDLGSVMDQVRHMMLVTVFVFIGIEGASVYSARAEKRADVGRATVIGFLG VLALLVLVNVLSLGIMTQPVLAQLQNPSLAGVLEHIVGPWGALLISLGLAVSLLGALLSW ALLCAEILYATARDKTMPAFLTKENANRAPVNALWLTNGMIQLFLLITLFSAGTYTSLIY LASSMILVPYLWSAAYAVLLCARGETYGQASARRMKDLCIGGVALCYAVWLLYAGGVKYL LLSALLYAPGVILFAQAKREQRQPLFTHVEKGVFACVMSGAGLAAYGLYSGFLAL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server